32.8602  0.403 (1.24%)		08-06 16:00
Open: 32.81 High: 32.91 Volume: 12,610		Pre. Close: 32.4571 Low: 32.5501 Market Cap: 42(M)

Short term
Mid term
Targets	6-month :	39.8	1-year :	46.49
Resists	First :	34.08	Second :	39.8
Pivot price	32.33
Supports	First :	32.43	Second :	31.41
MAs	MA(5) :	32.13	MA(20) :	32.45
	MA(100) :	31.53	MA(250) :	31.1
MACD	MACD :	0	Signal :	0.1
%K %D	K(14,3) :	60.3	D(3) :	38.7
RSI	RSI(14): 56.8
52-week	High :	37.15	Low :	23.26

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ OZEM ] has closed below upper band by 11.0%. Bollinger Bands are 46.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	32.96 - 33.09	33.09 - 33.23
Low:	32.22 - 32.36	32.36 - 32.5
Close:	32.63 - 32.87	32.87 - 33.12

Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.

Wed, 24 Jun 2026
5 Best GLP-1 Stocks for 2026 and How to Invest - The Motley Fool

Fri, 17 Apr 2026
3 Ways to Invest in the Growing GLP-1 Weight Loss Market - Yahoo Finance

Wed, 04 Feb 2026
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - TradingView

Fri, 30 Jan 2026
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha

Mon, 19 Jan 2026
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat

Mon, 12 Jan 2026
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Trends

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.